Compositions and methods of use
AssigneesUniversity of Florida Research Foundation, Inc., Yale University
InventorsChristian Jobin, Rachel Newsome, Jason Crawford, Joonseok Oh
Life of this patent
Estimating the term…
Abstract
Aspects of the disclosure relate to compositions and methods for modulating the immune response of a subject. The disclosure is based, in part, on compositions comprising one or more compounds that promotes interferon, e.g., interferon gamma (IFNγ), response in the gut microbiome of a subject and/or enhances the anti-tumor effects of certain immune checkpoint inhibitor (ICI) therapies. In some embodiments, the compositions are useful for treating a subject having cancer.
Claims39
A composition comprising a compound having a structure according to formula (Ia) or a pharmaceutically acceptable salt thereof:
A method for increasing interferon gamma (IFNγ) secretion in a subject, the method comprising administering to the subject a composition comprising a compound having a structure according to formula (Ia) or a pharmaceutically acceptable salt thereof:
A method for treating, ameliorating, or preventing cancer in a subject, the method comprising administering to the subject a composition comprising a compound having a structure according to formula (Ia) or a pharmaceutically acceptable salt thereof:
A composition comprising a cell-free isolate obtained from Bacteroides ovatus, wherein the cell free isolate comprises:
- (i) a first agent having a mass-to-charge ratio (m/z) of 417.2948;
- (ii) a second agent compound having a m/z of 296.25818;
- (iii) a third agent having a m/z of 317.20602;
- (iv) a fourth agent having a m/z of 298.2737;
- and
- (v) a fifth agent having a m/z of and 430.33078.
Dependencies are inferred from the claim text.